Hematological issues in critically ill patients with cancer

Critical Care Clinics
Karen S Carlson, Maria T DeSancho

Abstract

Patients with solid and hematologic malignancies presenting with major bleeding or thrombotic complications, potentially life-ending events in a cancer patient's clinical course, usually require admission to an intensive care unit (ICU), making their diagnosis and management even more important for the intensivist. Given the significant advances in the diagnosis and treatment of almost all types of cancers in recent years, the intensivist is likely to encounter an ever-increasing number of cancer patients in the ICU setting with these complications. Abnormal hemostasis can occur as a consequence of both the pathology and treatment of cancer. Because cancer can have multiple effects on hemostatic equilibrium, treatment of these complications can be more complex than in the general population. This article reviews the physiology of coagulation and fibrinolysis, with special attention to those aspects that are most frequently altered in the setting of malignancy. The pathophysiology of bleeding and thrombotic complications specific to critically ill cancer patients are then detailed, and the diagnostic and therapeutic strategies are discussed. Special emphasis is placed on new cancer medications that have an effect on hemostasis, ...Continue Reading

References

Jul 1, 1991·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·G ViganòG Remuzzi
Jun 1, 1986·The Journal of Experimental Medicine·R L NachmanC A Dinarello
Jul 1, 1980·Southern Medical Journal·V S Shen, E W Pollak
May 27, 1995·Lancet·P S WellsP Prandoni
Jan 1, 1997·Clinical Oncology : a Journal of the Royal College of Radiologists·M J Johnson
May 14, 1998·Seminars in Thrombosis and Hemostasis·J L FrancisA Amirkhosravi
Nov 26, 1998·The New England Journal of Medicine·H M Tsai, E C Lian
Apr 1, 1999·The New England Journal of Medicine·J S MenellK A Hajjar
May 20, 1999·The New England Journal of Medicine·R D Rosenberg, W C Aird
May 12, 2000·Hematology/oncology Clinics of North America·B Wiman
Nov 4, 2000·Expert Opinion on Investigational Drugs·A B Federici
Mar 7, 2001·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·C A SchifferUNKNOWN American Society of Clinical Oncology
Aug 23, 2001·Thrombosis Research·F R Rickles, A Falanga
Aug 30, 2001·Critical Care Clinics·M T DeSancho, J H Rand
Mar 29, 2002·The New England Journal of Medicine·David BergqvistUNKNOWN ENOXACAN II Investigators
Aug 1, 2002·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Louise J WalsheKent A Sepkowitz
Jul 11, 2003·The New England Journal of Medicine·Agnes Y Y LeeUNKNOWN Randomized Comparison of Low-Molecular-Weight Heparin versus Oral Anticoagulant Therapy for the Prevention of Recurrent Veno
Aug 26, 2003·Best Practice & Research. Clinical Haematology·Anna Falanga, Frederick R Rickles
Nov 12, 2003·Archives of Internal Medicine·Theodore E WarkentinJohn G Kelton
May 12, 2004·Current Pharmaceutical Design·John F Fullard
Sep 24, 2004·Cancer·Michael J WallaceMarshall E Hicks
Oct 1, 2004·Journal of Thrombosis and Haemostasis : JTH·C R M Hay
Nov 2, 2004·Annals of Hematology·Pavan S ReddyMervin A Sahud
Feb 9, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Agnes Y Y LeeMark N Levine
Feb 11, 2005·JAMA : the Journal of the American Medical Association·Jeanet W BlomFrits R Rosendaal
Feb 25, 2005·The New England Journal of Medicine·Stephan A MayerUNKNOWN Recombinant Activated Factor VII Intracerebral Hemorrhage Trial Investigators
Apr 26, 2005·American Journal of Hematology·C FozzaM Longinotti
May 20, 2005·The New England Journal of Medicine·Jan O Friedrich
Jul 5, 2005·Critical Care Clinics·Thomas G DeLoughery

❮ Previous
Next ❯

Citations

Oct 10, 2012·Cardiovascular Journal of Africa·Shokoufeh HajsadeghiHamidezar Pouraliakbar
Jun 1, 2018·Thoracic Cancer·Kentaro NakanoYasutsugu Fukushima
Jan 5, 2019·Journal of Pediatric Hematology/oncology·Akram Mesleh ShayebUlrike M Reiss
Feb 11, 2014·Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis·Grażyna GadomskaRadosław Wieczór
Dec 17, 2014·Cancer Control : Journal of the Moffitt Cancer Center·Thomas WatkinsJeffrey McCullough

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cancer Imaging

Imaging techniques, including CT and MR, have become essential to tumor detection, diagnosis, and monitoring. Here is the latest research on cancer imaging.

Angiogenesis Inhibitors to Treat Cancer

Cancer treatments including angiogenesis inhibitors prevent tumor cells from receiving nutrients and oxygen. Here is the latest research on angiogenesis inhibitors for the treatment of cancer.

Breast Invasive Carcinoma (Keystone)

Invasive breast cancers indicate a spread into breast tissues and lymph nodes. Here are the latest discoveries pertaining to breast invasive carcinomas.

Blood Coagulation Signaling Pathways

Coagulation is the process by which a blood clot is formed. This process includes both the formation of a platelet plug as well as a cascade of clotting factors resulting in the formation of fibrin strands. Find the latest research on coagulation signaling pathways here.

Allergy and Asthma

Allergy and asthma are inflammatory disorders that are triggered by the activation of an allergen-specific regulatory t cell. These t cells become activated when allergens are recognized by allergen-presenting cells. Here is the latest research on allergy and asthma.

Blood Clotting Disorders

Thrombophilia includes conditions with increased tendency for excessive blood clotting. Blood clotting occurs when the body has insufficient amounts of specialized proteins that make blood clot and stop bleeding. Here is the latest research on blood clotting disorders.

Anemia

Anemia develops when your blood lacks enough healthy red blood cells. Anemia of inflammation (AI, also called anemia of chronic disease) is a common, typically normocytic, normochromic anemia that is caused by an underlying inflammatory disease. Here is the latest research on anemia.

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

Breast Invasive Carcinoma

Invasive breast cancers indicate a spread into breast tissues and lymph nodes. Here are the latest discoveries pertaining to breast invasive carcinomas.

Related Papers

World Journal for Pediatric & Congenital Heart Surgery
Therese M GigliaJames S Tweddell
Expert Opinion on Investigational Drugs
R Venkataraman, J A Kellum
Expert Opinion on Investigational Drugs
R Venkataraman, J A Kellum
© 2022 Meta ULC. All rights reserved